Search research articles
Contact Us
Filters
Showing results (441-450 of 491) with videos related to
Page
of 50
Sort By:
Arxiv
|
November 24, 2025
ITRUSST Consensus on Biophysical Safety for Transcranial Ultrasound Stimulation
Jean-François Aubry, David Attali, Mark E Schafer, et al.
Brain Stimulation
|
October 10, 2025
ITRUSST consensus on biophysical safety for transcranial ultrasound stimulation
Jean-François Aubry, David Attali, Mark E Schafer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 9, 2019
Brentuximab Vedotin plus Chemotherapy in North American Subjects with Newly Diagnosed Stage III or IV Hodgkin Lymphoma
Radhakrishnan Ramchandren, Ranjana H Advani, Stephen M Ansell, et al.
Blood Advances
|
November 23, 2020
Durable ibrutinib responses in relapsed/refractory marginal zone lymphoma: long-term follow-up and biomarker analysis
Ariela Noy, Sven de Vos, Morton Coleman, et al.
Blood
|
June 20, 2023
Pembrolizumab plus vorinostat induces responses in patients with Hodgkin lymphoma refractory to prior PD-1 blockade
Matthew Mei, Lu Chen, James Godfrey, et al.
Blood
|
July 31, 2020
A phase 1b study of AFM13 in combination with pembrolizumab in patients with relapsed or refractory Hodgkin lymphoma
Nancy L Bartlett, Alex F Herrera, Eva Domingo-Domenech, et al.
Vaccine
|
March 12, 2025
Feasibility of cohort event monitoring and assessment of reactogenicity and adverse events among a cohort of AstraZeneca and Moderna COVID-19 vaccine recipients in Nigeria, 2021
Omotayo Bolu, Oluwafemi D Alo, Emem Iwara, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 22, 2025
Efficacy and Safety of Capivasertib (AZD5363), a Potent, Oral Pan-AKT Inhibitor, in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (CAPITAL)
Daniel J Hodson, Geoffrey Shouse, Ho-Jin Shin, et al.
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie
|
November 25, 2020
Canadian recommendations for training and performance in basic perioperative point-of-care ultrasound: recommendations from a consensus of Canadian anesthesiology academic centres
Massimiliano Meineri, Ramiro Arellano, Gregory Bryson, et al.
The Oncologist
|
March 19, 2017
Academic Cancer Center Phase I Program Development
Arthur E Frankel, Keith T Flaherty, George J Weiner, et al.
Page
of 50
Search research articles
Search
Showing results (441-450 of 491) with videos related to
Sort By:
Page
of 50
Arxiv
|
November 24, 2025
ITRUSST Consensus on Biophysical Safety for Transcranial Ultrasound Stimulation
Jean-François Aubry, David Attali, Mark E Schafer, et al.
Brain Stimulation
|
October 10, 2025
ITRUSST consensus on biophysical safety for transcranial ultrasound stimulation
Jean-François Aubry, David Attali, Mark E Schafer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 9, 2019
Brentuximab Vedotin plus Chemotherapy in North American Subjects with Newly Diagnosed Stage III or IV Hodgkin Lymphoma
Radhakrishnan Ramchandren, Ranjana H Advani, Stephen M Ansell, et al.
Blood Advances
|
November 23, 2020
Durable ibrutinib responses in relapsed/refractory marginal zone lymphoma: long-term follow-up and biomarker analysis
Ariela Noy, Sven de Vos, Morton Coleman, et al.
Blood
|
June 20, 2023
Pembrolizumab plus vorinostat induces responses in patients with Hodgkin lymphoma refractory to prior PD-1 blockade
Matthew Mei, Lu Chen, James Godfrey, et al.
Blood
|
July 31, 2020
A phase 1b study of AFM13 in combination with pembrolizumab in patients with relapsed or refractory Hodgkin lymphoma
Nancy L Bartlett, Alex F Herrera, Eva Domingo-Domenech, et al.
Vaccine
|
March 12, 2025
Feasibility of cohort event monitoring and assessment of reactogenicity and adverse events among a cohort of AstraZeneca and Moderna COVID-19 vaccine recipients in Nigeria, 2021
Omotayo Bolu, Oluwafemi D Alo, Emem Iwara, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 22, 2025
Efficacy and Safety of Capivasertib (AZD5363), a Potent, Oral Pan-AKT Inhibitor, in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (CAPITAL)
Daniel J Hodson, Geoffrey Shouse, Ho-Jin Shin, et al.
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie
|
November 25, 2020
Canadian recommendations for training and performance in basic perioperative point-of-care ultrasound: recommendations from a consensus of Canadian anesthesiology academic centres
Massimiliano Meineri, Ramiro Arellano, Gregory Bryson, et al.
The Oncologist
|
March 19, 2017
Academic Cancer Center Phase I Program Development
Arthur E Frankel, Keith T Flaherty, George J Weiner, et al.
Page
of 50